Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02242266 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium low dose
DRUG: Tiotropium medium dose
DRUG: Spiriva® HandiHaler® high dose
DRUG: Placebo via the blue HandiHaler®
DRUG: Placebo via the grey HandiHaler®

Sponsor

Boehringer Ingelheim